Harris Williams Advises Knox Lane on its Strategic Investment in Fingerpaint
January 04 2021 - 11:39AM
Business Wire
Harris Williams, a global investment bank specializing in
M&A advisory services, announces it advised Knox Lane, a
leading middle market investment firm focused on the consumer and
services sectors, on its strategic investment in Fingerpaint, a
full-service health and wellness marketing agency with five offices
across the U.S. The transaction was led by Paul Hepper of the
Harris Williams Healthcare & Life Sciences (HCLS) Group and Dan
Linsalata of the firm’s Technology Group.
“Fingerpaint’s innovative approach to providing marketing
services to pharmaceutical, rare disease and gene therapy clients
has driven the company’s growth over the past 12 years,” said Paul
Hepper, a managing director at Harris Williams. “Knox Lane will be
a fantastic partner to Fingerpaint as it embarks on its next
chapter.”
Dan Linsalata, a director at Harris Williams, added, “Knox
Lane’s investment in Fingerpaint comes amidst deep investor
interest in the technology-enabled pharma marketing services
sector. This fragmented end market is benefitting from numerous
positive tailwinds and firms with innovative offerings and strong
backing will be well positioned for success.”
Formed in 2019 and based in San Francisco, Knox Lane is a middle
market investment firm led by and comprised of a team of
accomplished investors and operators with a shared work history and
a strong track record of partnering with leading companies to
accelerate transformational growth. Knox Lane employs an
investor-operator mindset and seeks to provide support across a
number of business components, including human capital, brand
management, end-to-end digital transformation, sourcing, supply
chain and logistics, strategic acquisitions and business
development.
Independent by design, with integrated talent across five
offices in New York, Pennsylvania, Arizona, New Jersey and
California, Fingerpaint is built on a foundation of empathy and at
its core is committed to creating and executing meaningful brand
experiences for healthcare providers, care partners and patients.
In 2020, Fingerpaint acquired 1798, a market access and
commercialization firm located in La Jolla, California, adding to
its portfolio of services in support of biopharma customers. The
agency also launched Photo 51, a gene therapy consultancy.
Fingerpaint was named 2019 Agency of the Year by Med Ad News, and
in 2018, it won the Heart Award from Med Ad News for its commitment
to philanthropy and social causes. Additionally, it has been on
Inc. Magazine's list of the 5,000 Fastest-Growing Companies for the
past seven years.
Harris Williams, an investment bank specializing in M&A
advisory services, advocates for sellers and buyers of companies
worldwide through critical milestones and provides thoughtful
advice during the lives of their businesses. By collaborating as
one firm across Industry Groups and geographies, the firm helps its
clients achieve outcomes that support their objectives and
strategically create value. Harris Williams is committed to
execution excellence and to building enduring, valued relationships
that are based on mutual trust. Harris Williams is a subsidiary of
the PNC Financial Services Group, Inc. (NYSE: PNC).
The Harris Williams HCLS Group has experience across a broad
range of sectors, including healthcare providers; payors and payor
services; outsourced pharmaceutical services; medical device supply
chain; healthcare IT; and pharmacy. For more information on the
HCLS Group and other recent transactions, visit the HCLS Group’s
section of the Harris Williams website.
The Harris Williams Technology Group advises leading private and
public companies, entrepreneurs, private equity firms and venture
capital firms on mergers and acquisitions and capital-raising
transactions worldwide. The Technology Group has deep domain
expertise in the IT Services, Software/SaaS and Internet &
Digital Media segments, with particular emphasis on specific
verticals including education technology, data analytics, energy
technology, fintech, public sector, and supply chain/logistics—with
a dedicated healthcare technology (HCIT) practice. Across
verticals, the firm also advises technology services and networking
solutions businesses. For more information on the Technology Group
and its recent transactions, visit the Technology Group’s section
of the Harris Williams website.
Harris Williams LLC is a registered broker-dealer and member of
FINRA and SIPC. Harris Williams & Co. Ltd is a private limited
company incorporated under English law with its registered office
at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered
with the Registrar of Companies for England and Wales (registration
number 07078852). Harris Williams & Co. Ltd is authorized and
regulated by the Financial Conduct Authority. Harris Williams &
Co. Corporate Finance Advisors GmbH is registered in the commercial
register of the local court of Frankfurt am Main, Germany, under
HRB 107540. The registered address is Bockenheimer Landstrasse
33-35, 60325 Frankfurt am Main, Germany (email address:
hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery
H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a
trade name under which Harris Williams LLC, Harris Williams &
Co. Ltd and Harris Williams & Co. Corporate Finance Advisors
GmbH conduct business.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210104005597/en/
Media inquiries: Julia Moore media@harriswilliams.com
PNC Financial Services (NYSE:PNC)
Historical Stock Chart
From Aug 2024 to Sep 2024
PNC Financial Services (NYSE:PNC)
Historical Stock Chart
From Sep 2023 to Sep 2024